Gates Foundation Announces Additional $250M For COVID-19 Diagnostics, Treatments, Vaccines; World ‘Not On Track’ For Equitable Vaccine Distribution, CEO Suzman Says In Devex Interview

Devex: Gates Foundation COVID-19 commitment reaches $1.75B with latest pledge
“The world is ‘not on track’ for an equitable COVID-19 vaccine rollout, according to Mark Suzman, CEO of the Bill & Melinda Gates Foundation. Despite the unprecedented pace of progress in research and development for COVID-19 vaccines, a number of barriers stand in the way of getting these scientific breakthroughs to everyone who needs them, Suzman told Raj Kumar, president and editor-in-chief at Devex, in an interview for Devex World…” (Cheney, 12/10).

Seattle Times: Gates Foundation boosts funding to get coronavirus vaccines to the world’s poorest people
“…The giant Seattle philanthropy announced late Wednesday that it will spend an additional $250 million — its single largest contribution so far — to accelerate development and delivery of diagnostics, drugs, and vaccines. … The latest donation brings the foundation’s total pandemic-related grants to $1 billion. The foundation has also earmarked $750 million for forgivable loans and other financing mechanisms through an investment fund that reinvests returns in charitable causes…” (Doughton, 12/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.